Publications by authors named "Sebastien Walchli"

Claim this Profile
P
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors.
Rafaela Abrantes, Christopher Forcados, David J Warren, Liliana Santos-Ferreira, Karianne Giller Fleten

Cell Rep Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LILRB1-directed CAR-T cells for the treatment of hematological malignancies.
Katsiaryna Marhelava, Klaudyna Fidyt, Monika Pepek, Marta Krawczyk, Christopher Forcados

Leukemia· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for production of tonic CAR T cells with dasatinib.
Léa Rosselle, Thibault Leray, Sandy Joaquina, Benjamin Caulier, Emmet McCormack

STAR Protoc· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.
Marta Krawczyk, Narcis Fernandez-Fuentes, Klaudyna Fidyt, Tomasz Winiarski, Monika Pepek

bioRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for the development of a bioluminescent AML-PDX mouse model for the evaluation of CAR T cell therapy.
Mireia Mayoral Safont, Calum Leitch, Mihaela Popa, May Eriksen Gjerstad, Benjamin Caulier

STAR Protoc· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer.
Solrun Melkorka Maggadottir, Svein Dueland, Nadia Mensali, Hanne Hamre, Per Arne Andresen

Mol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia.
Benjamin Caulier, Sandy Joaquina, Pascal Gelebart, Tara Helén Dowling, Fatemeh Kaveh

Cell Rep Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.
Malgorzata Bobrowicz, Aleksandra Kusowska, Marta Krawczyk, Andriy Zhylko, Christopher Forcados

Oncoimmunology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro re-challenge of CAR T cells.
Clara Helena Klee, Alicia Villatoro, Nicholas Paul Casey, Else Marit Inderberg, Sébastien Wälchli

Methods Cell Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16.
Nicholas P Casey, Katrin Kleinmanns, Christopher Forcados, Pascal F Gelebart, Sandy Joaquina

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient chimeric antigen receptor targeting of a central epitope of CD22.
Nicholas Paul Casey, Clara Helena Klee, Anne Fåne, Benjamin Caulier, Agnieszka Graczyk-Jarzynka

J Biol Chem· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.
Nadia Mensali, Hakan Köksal, Sandy Joaquina, Patrik Wernhoff, Nicholas P Casey

Nat Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of CAR T cell metabolism in an optimized protocol.
Sandy Joaquina, Christopher Forcados, Benjamin Caulier, Else Marit Inderberg, Sébastien Wälchli

Front Bioeng Biotechnol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression.
Kanutte Huse, Baoyan Bai, Vera I Hilden, Lise K Bollum, Thea K Våtsveen

J Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT).
Sólrún Melkorka Maggadóttir, Gunnar Kvalheim, Patrik Wernhoff, Stein Sæbøe-Larssen, Mona-Elisabeth Revheim

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo experimental mouse model to test CD19CAR T cells generated with different methods.
Anne Fåne, Marit Renée Myhre, Else Marit Inderberg, Sebastien Wälchli

Methods Cell Biol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How CAR T Cells Breathe.
Christopher Forcados, Sandy Joaquina, Nicholas Paul Casey, Benjamin Caulier, Sébastien Wälchli

Cells· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-Ts: new perspectives in cancer therapy.
Rafaela Abrantes, Henrique O Duarte, Catarina Gomes, Sébastien Wälchli, Celso A Reis

FEBS Lett· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells.
Malgorzata Bajor, Agnieszka Graczyk-Jarzynka, Katsiaryna Marhelava, Anna Burdzinska, Angelika Muchowicz

J Immunother Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Built-in" PD-1 blocker to rescue NK-92 activity from PD-L1-mediated tumor escape mechanisms.
Nadia Mensali, Pierre Dillard, Artem Fayzullin, Hakan Köksal, Gustav Gaudernack

FASEB J· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rab7b regulates dendritic cell migration by linking lysosomes to the actomyosin cytoskeleton.
Katharina Vestre, Irene Persiconi, Marita Borg Distefano, Nadia Mensali, Noemi Antonella Guadagno

J Cell Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial CAR design improves target restriction.
Hakan Köksal, Pierre Dillard, Asta Juzeniene, Gunnar Kvalheim, Erlend B Smeland

J Biol Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors.
Pierre Dillard, Nicholas Casey, Sylvie Pollmann, Patrik Vernhoff, Gustav Gaudernack

Oncoimmunology· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic Control of CAR T Cells.
Benjamin Caulier, Jorrit M Enserink, Sébastien Wälchli

Int J Mol Sci· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Id2 Represses Aldosterone-Stimulated Cardiac T-Type Calcium Channels Expression.
Jumpei Ito, Tomomi Minemura, Sébastien Wälchli, Tomoaki Niimi, Yoshitaka Fujihara

Int J Mol Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis